Northwest Biotherapeutics (NWBO) 10-K2009 FY Annual report

Filed: 15 Apr 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accrual, ASC, authoritative, bench, beneficiary, Bermuda, biomarker, bought, Brown, buyout, Califormia, career, Carnegie, Charlesbridge, Chinese, choice, chronology, clarify, clarifying, Clinton, Codification, College, Compnay, Conclusion, conference, confusion, Consul, COSO, counterpart, creditor, culminating, curve, daily, Dale, Dartmouth, David, deal, default, Democratic, diligence, distressed, dozen, dropped, educated, enterprise, entrepreneur, EU, external, externally, familiar, Farmer, Filer, Franklin, Glenn, Governor, Haute, housing, humeral, immaterial, immunocellular, inactive, indirectly, indistinguishable, introduced, inventory, John, jurisdiction, Kerry, Lane, LB, led, lender, lump, Madarex, Michael, misleading, Montgomery, newer, panel, payout, presidential, Provenge, publishing, qualitative, quantitative, quantity, ready, recieved, recipient, relocated, remanded, renewed, reorganization, Robert, Ron, Rosalind, rose, sharply, sitting, Sober, source, spring, stay, structure, succeeded, summer, Sunnyvale, supplemented, Synteract, systematic, taught, Tennessee, TFF, thing, thought, transplant, treasurer, unaffected, unbilled, underwent, undeterminable, unilateral, unilaterally, variable, verification

Removed: abandonment, accretion, accrue, accurate, acquired, addendum, adjust, adjusting, adjustment, allocated, allocation, APB, appealed, arose, banker, billion, borrowed, calculating, cancelled, ceased, choose, claiming, climate, close, compounded, concentrating, conserving, consummation, contemplated, contended, coupling, customary, DakoCytomation, declaratory, derivative, diagnose, directed, discontinue, earn, enabled, enactment, enrolling, entitled, essential, estimation, evaluated, exclusively, FIN, final, fixed, forgiven, fourth, heart, hedge, humoral, hypothetical, incidence, inclusive, increasing, indemnification, inherently, input, interpretation, leased, Lee, lifetime, liquidated, match, maximizing, metropolitan, milestone, minimal, motion, negotiation, NY, owe, pension, permitted, pro, proportional, rata, receivable, recovered, refund, register, relief, remediation, repayment, reply, representation, resale, residual, restructure, restructuring, revaluation, revalued, royalty, ruled, SAB, securing, selectivity, sensitivity, settled, shifted, specificity, successive, Supreme, syndicate, tenant, thereof, thereon, thirteen, timing, transition, underlying, undertaken, unforeseen, unspecified, updated, vacate, vulnerable, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NWBO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Northwest Biotherapeutics, Inc. and its subsidiary (the “Company”) on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission (the "Report"), I, Alton L. Boynton certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; as amended, and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 15 , 2010	/s/ ALTON L. BOYNTON
	Alton L. Boynton
	President and Chief Executive Officer (Principal Executive
	Officer)
	(Principal Executive, Financial and Accounting Officer)

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company as part of the Report or as a separate disclosure document for purposes of Section 18 or any other provision of the Securities Exchange Act of 1934, as amended.